A trial of dorzolamide for glaucoma

Ophthalmic Surgery and Lasers

Volumn 29, Issue 9, 1998, Pages 728-732

  Gillies, W E ^a,b   Brooks, A M V ^a  

^a Ear Hospital   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEMATOLOGIC DISEASE; HUMAN; HYPERSENSITIVITY; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; SURGICAL TECHNIQUE; TOPICAL DRUG ADMINISTRATION;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; CARBONIC ANHYDRASE INHIBITORS; CHILD; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; MIOTICS; SULFONAMIDES; THIOPHENES; TREATMENT OUTCOME;

EID: 0031685999     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Grant WM, Schuman JS, eds. Acetazolamide. In: Toxicology of the Eye, 4th ed. Springfield, IL: Charles C Thomas; 1993:43-48.
2. Strahlman E, Tipping R, Vogel R, the International Dorzolamide Study Group. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol. 1995;113:1009-1016.
3. Simpson AJ, Gray TB, Ballantyne C. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study. Aust N Z J Ophthalmol. 1996;24:39-42.
4. Gillies WE, Brooks AMV. A clinical trial of MK-507, Trusopt, for raised intraocular pressure: the Australian experience. Aust N Z J Ophthalmol. 1996;24:111-115.
5. Strahlman ER, Vogel R, Tipping R, Clineschmidt CM, the Dorzolamide Addivity Study Group. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology. 1996;103:1283-1293.
6. Maus TL, Larsson L-I, McLaren JW, Brubaker RF. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. Arch Ophthalmol. 1997;115:45-49.
7. Donohue EK, Wilensky JT. Trusopt: a topical carbonic anhydrase inhibitor. J Glaucoma. 1996;5:68-74.
8. Strahlman E, Tipping R, Vogel R, the Dorzolamide Dose-response Study Group. A six-week dose response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Am J Ophthalmol. 1996;122:183-194.
9. Fraunfelder FT, Meyer SM, Bagby GC, Dreis MW. Hematologic reactions to carbonic anhydrase inhibitors. Am J Ophthalmol. 1985;100:79-81.
10. Shapiro S, Fraunfelder FT. Acetazolamide and aplastic anemia. Am J Ophthalmol. 1992;113:328-330.
11. Fraunfelder FT, Fraunfelder FW. Short-term use of carbonic anhydrase inhibitors and hematologic side effects. Arch Ophthalmol. 1992;110:446-447.